Roxas, Antonio, JR.. D.

HRN: 25-17-77  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2024
METRONIDAZOLE 500MG (TAB)
06/07/2024
06/13/2024
PO
500 Mg/tab, 1 Tab
Q8
H. Pylori Infection;
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: